Low density lipoprotein landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
(4 intermediate revisions by the same user not shown) | |||
Line 8: | Line 8: | ||
{| style="font-size:120%" | {| style="font-size:120%" | ||
|- | |- | ||
| WOSCOPS (pravastatin) | | [[WOSCOPS Trial]] ([[pravastatin]]) | ||
|- | |- | ||
| AFCAPS/TexCAPS (lovastatin) | | [[AFCAPS/TexCAPS Trial]] ([[lovastatin]]) | ||
|- | |- | ||
| [[4S Trial]] (simvastatin) | | [[4S Trial]] ([[simvastatin]]) | ||
|- | |- | ||
| Heart Protection Study (simvastatin) | | [[Heart Protection Study]] ([[simvastatin]]) | ||
|- | |- | ||
| ALLHAT | | [[ALLHAT]] ([[pravastatin]]) | ||
|- | |- | ||
| PROSPER | | [[PROSPER Trial]] ([[pravastatin]]) | ||
|- | |- | ||
| ASCOT-LLA | | [[ASCOT-LLA Trial]] ([[atorvastatin]]) | ||
|- | |- | ||
| PROVE IT | | [[PROVE IT-TIMI 22 Trial]] ([[pravastatin]] or [[atorvastatin]]) | ||
|- | |- | ||
| [[ASTEROID Trial]] (rosuvastatin) | | [[ASTEROID Trial]] ([[rosuvastatin]]) | ||
|- | |- | ||
| | | [[CARDS]] ([[atorvastatin]]) | ||
|- | |- | ||
| [[ | | [[ASPEN]] ([[atorvastatin]]) | ||
|- | |- | ||
| | | [[MEGA Trial]] ([[pravastatin]]) | ||
|- | |- | ||
| [[SATURN Trial]] (atorvastatin, rosuvastatin) | | [[CORONA Trial]] ([[rosuvastatin]]) | ||
|- | |||
| [[JUPITER Trial]] ([[rosuvastatin]]) | |||
|- | |||
| [[SATURN Trial]] ([[atorvastatin]], [[rosuvastatin]]) | |||
|} | |} | ||
Latest revision as of 04:30, 29 September 2014
Low Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Low density lipoprotein landmark trials On the Web |
American Roentgen Ray Society Images of Low density lipoprotein landmark trials |
Risk calculators and risk factors for Low density lipoprotein landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Landmark Trials
Statin
Multiple Lipid Lowering Drugs
HARP Study |